PROPRIETARY TOXINS


We have developed a panel of proprietary toxins derived from natural cytotoxic compounds with our in-house chemical design and synthesis to optimize performance of our payloads. Various structural modifications of known compounds were implemented through our in-house chemical design and synthesis to address issues such as efficacy, toxicity, conjugation and stability.

These toxins have been screened on multiple tumor cell lines and through in vivo studies.Our selection of toxins provides a spectrum of different mode of actions including tubulin inhibitors, RNA polymerase inhibitors, and DNA damaging agents.